Merav Bassan - Jul 11, 2024 Form 4 Insider Report for BiomX Inc. (PHGE)

Role
Chief Development Officer
Signature
/s/ Merav Bassan
Stock symbol
PHGE
Transactions as of
Jul 11, 2024
Transactions value $
$0
Form type
4
Date filed
7/15/2024, 06:46 PM
Previous filing
Dec 13, 2023
Next filing
Sep 18, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHGE Common Stock Options - Right to Buy Award $0 +950K $0.00 950K Jul 11, 2024 Common Stock 950K $0.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on July 11, 2025, and the remainder vesting in 12 equal quarterly installments over three years.